Talaris Therapeutics, Inc.
USD2.72
-0.02 (-0.73%)
CEO
Mary Kay Fenton
IPO Date
2021-05-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.78
Prev. Close
$2.74
Day Low
$2.69
Day High
$2.79
52W Low
$0.89
52W High
$3.29
Market Cap
$0.12B
Volume
0.30M
| 0 |
| $0.00 |
| 27 Oct 2023 | Castelein Caley | director | P-Purchase | Acquired | 15,800 | $14.55 |
| 27 Oct 2023 | Castelein Caley | director | P-Purchase | Acquired | 4,200 | $12.07 |
| 23 Oct 2023 | MIDDLEKAUFF W BRADFORD | CBO, GC and Secretary | A-Award | Acquired | 124,991 | $7.90 |
| 23 Oct 2023 | MIDDLEKAUFF W BRADFORD | CBO, GC and Secretary | A-Award | Acquired | 69,201 | $0.00 |
| 23 Oct 2023 | MIDDLEKAUFF W BRADFORD | CBO, GC and Secretary | A-Award | Acquired | 46,774 | $9.46 |
| 23 Oct 2023 | MIDDLEKAUFF W BRADFORD | officer | Disposed | 0 | $0.00 |
| 23 Oct 2023 | CHYUNG YUNG H. | Chief Medical Officer | A-Award | Acquired | 144,215 | $7.90 |
| 23 Oct 2023 | CHYUNG YUNG H. | Chief Medical Officer | A-Award | Acquired | 73,211 | $9.46 |